Outcome
    Moderate Evidence
    Effectiveness 4/5

    Myo-Inositol for Fertility Support Female

    Myo-inositol restores ovulation and improves egg quality in PCOS with strong meta-analytic support; benefits in non-PCOS fertility are less established.

    Overview

    Myo-inositol has moved from supplement shelf to something close to standard adjunct care in PCOS-related infertility, which is where nearly all of its fertility evidence sits.
    Randomised trials in women with polycystic ovary syndrome show myo-inositol restores ovulation in a substantial proportion of participants, improves insulin sensitivity and androgen profiles, and in IVF settings improves oocyte and embryo quality while reducing the gonadotropin dose required. Comparisons with metformin generally show similar metabolic effects with far better tolerability. Outside PCOS the picture is thinner. For unexplained infertility, age-related decline or male-factor cases, myo-inositol is not an established intervention. Cochrane-level assessments also note that live birth data remain limited.

    No studies are currently linked to this pairing

    This page reflects published clinical literature and conventional dosing rather than trial data attached to this outcome in our library.

    How It Works

    Myo-inositol is the precursor to inositol triphosphate, a second messenger in FSH signal transduction within the ovary. It also acts as an insulin sensitiser: inositol phosphoglycans mediate part of insulin's intracellular action, and women with PCOS show impaired conversion of myo-inositol to D-chiro-inositol in some tissues.
    This matters because hyperinsulinaemia drives ovarian androgen production and disrupts follicular development. Lowering insulin resistance reduces androgens, which restores the hormonal environment for normal follicle selection and ovulation. Myo-inositol is also concentrated in follicular fluid, where higher levels correlate with better oocyte quality - the proposed basis for the IVF findings. The ovary appears to depend on local myo-inositol availability more than most tissues.

    Dosing & Protocol

    Dosing is well standardised, and the physiological ratio with D-chiro-inositol is the convention.
    ContextDoseFormTiming
    Standard protocol2 g twice daily (4 g total)Myo-inositol powder or capsulesMorning and evening
    Combination product4 g myo-inositol + 100 mg D-chiro-inositol daily40:1 ratio blendDivided doses
    With folic acid4 g myo-inositol + 400 mcg folic acidCommon trial formulationDaily
    Assessment window3-6 months-Track cycle regularity and ovulation; IVF benefits assessed per cycle

    The 40:1 ratio is deliberate

    That is the physiological plasma ratio of myo- to D-chiro-inositol. High-dose D-chiro-inositol alone has been associated with worse oocyte quality, so more is not better.

    Evidence

    There are currently no studies linked to this pairing in our library, so no study list is shown.
    Multiple randomised trials and meta-analyses in PCOS report restored ovulation in roughly 60 to 70 percent of participants over three to six months, improved HOMA-IR, reduced testosterone and improved cycle regularity. IVF studies report better oocyte and embryo quality and reduced gonadotropin requirements, and head-to-head comparisons with metformin show comparable metabolic effects with fewer gastrointestinal side effects. The caveats are real. Many trials are small and open-label, formulations and endpoints vary, live birth rates are inconsistently reported, and evidence outside PCOS is minimal. Cochrane reviews of inositol for subfertility have rated the certainty of live birth evidence as low.

    PCOS-specific, ovulation-focused

    Strong for restoring ovulation in PCOS. Live birth evidence is weaker, and non-PCOS infertility is unstudied.

    Safety

    Myo-inositol is remarkably well tolerated. At 4 g daily, side effects are uncommon; nausea, bloating or loose stools appear mainly at doses above 12 g daily, which is well beyond fertility protocols.

    Fertility problems deserve proper investigation

    If you have been trying for 12 months (or 6 months over age 35), seek assessment. Tubal, uterine, thyroid and male factors need identifying, and no supplement addresses them.

    Data in pregnancy are limited, though inositol has been studied for gestational diabetes prevention with no safety concerns emerging. Most protocols continue folic acid alongside. Tell your fertility clinic what you are taking, since it may interact with how they interpret cycle response and dose gonadotropins.

    Interactions & Conflicts

    Interactions are few, and most reflect additive metabolic effects.
    Interacts withSeverityMechanismAction
    Metformin
    low
    Both improve insulin sensitivity; often used together or as alternativesReasonable to combine under medical guidance
    Clomiphene or letrozole
    low
    Inositol may improve response to ovulation inductionUse only with your clinic's knowledge
    High-dose D-chiro-inositol
    moderate
    Excess D-chiro-inositol has been linked to poorer oocyte qualityStick to 40:1 myo to D-chiro formulations
    Glucose-lowering medication
    moderate
    Additive glucose loweringMonitor blood glucose
    Folic acid
    low
    Standard co-formulation; complementaryContinue as advised preconception

    References

    No studies are currently linked to this pairing, so no reference list is available. This section will populate as evidence is added to the library.

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.